Europe-wide Patent Granted for G+ in Golf Balls

RNS Number : 7227T
Directa Plus PLC
29 March 2021
 

This is a Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

29 March 2021

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Europe-wide Patent Granted for G+ in Golf Balls

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company has been granted an EU-wide patent covering the use of its G+® graphene in golf ball applications.  The reference date for the patent is 23 December 2016.

 

The patent covers a family of formulations and compounds containing G+® graphene nanoplatelets for golf ball applications.  Using these compounds at different loadings provides the basis for developing a new generation of high-performance golf balls aimed at both the professional and recreational markets.  For professionals, G+® can be used to enhance the hard-core of golf balls to maximise shot distance, without losing lateral control.  For amateurs, a different formulation of G+® can be used to increase distance while at the same time maximising control.

 

Following the grant of patent, Directa Plus will commence a selection process for a partner to commercialise the technology.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "The award of a Europe-wide patent for our G+® technology in golf balls is the first step towards addressing a very large global market.  Our technology can deliver material benefits in terms of both distance and control to professional and recreational golfers.  We look forward to working with our chosen partner to designing and launching a new generation of high-performance golf balls."

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald / Pete Lynch

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Rick Thompson / Phil Davies

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson / Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products).  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products.  All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASELFAAEFSEID
UK 100

Latest directors dealings